Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients

View source ↗

Summary

A clinical trial evaluating the safety and effectiveness of darunavir for HIV-1 infection in Filipino patients has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Human Immunodeficiency Virus-Type 1 | Status: WITHDRAWN